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In order to study the diﬀerential protein expression in complex biological samples, strategies for rapid, highly reproducible and
accurate quantiﬁcation are necessary. Isotope labeling and ﬂuorescent labeling techniques have been widely used in quantitative
proteomics research. However, researchers are increasingly turning to label-free shotgun proteomics techniques for faster, cleaner,
and simpler results. Mass spectrometry-based label-free quantitative proteomics falls into two general categories. In the ﬁrst are
the measurements of changes in chromatographic ion intensity such as peptide peak areas or peak heights. The second is based on
the spectral counting of identiﬁed proteins. In this paper, we will discuss the technologies of these label-free quantitative methods,
statistics, available computational software, and their applications in complex proteomics studies.
1.Introduction
Mass spectrometry plays a central role in proteomics [1]. In
addition to global proﬁling of the proteins present within
a system at a given time, information on the level of
protein expression is increasingly required in proteomics
studies [1, 2]. Protein separation and comparison by two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE),
followed by mass spectrometry (MS) or tandem mass
spectrometry (MS/MS) identiﬁcation is the classical method
for quantitative analysis of protein mixtures [3]. In this
method, the intensity of the protein stain is used to make
a determination regarding the quantity of a particular
protein. The development of 2D Fluorescence Diﬀerence Gel
Electrophoresis (2D-DIGE) gives more accurate and reliable
quantiﬁcationinformationofproteinabundancebecausethe
samples to be compared are run together on the same gel,
eliminating potential gel-to-gel variation [4]. However, spots
on a given 2D gel often contain more than one protein,
making quantiﬁcation ambiguous since it is not immediately
apparent which protein in the spot has changed. In addition,
any 2D gel approach is subject to the restrictions imposed
by the gel method, which include limited dynamic range,
diﬃculty handling hydrophobic proteins, and diﬃculty
detecting proteins with extreme molecular weights and pI
values.
Thedevelopmentofnon-gel-based,“shotgun”proteomic
techniques such as Multidimensional Protein Identiﬁcation
(MudPIT) has provided powerful tools for studying large-
scaleproteinexpressionandcharacterizationincomplexbio-
logicalsystems[5,6].Non-gel-basedquantitativeproteomics
methods have, therefore, also been developed signiﬁcantly in
recent years. Because the chemical and physical properties
of isotope labeled compounds are identical to properties of
their natural counterparts except in mass, isotope labeled
molecules were incorporated into mass spectrometry-based
proteomics methods as internal standards or relative ref-
erences. A number of stable isotope labeling approaches
have been developed for “shotgun” quantitative proteomic
analysis. These include Isotope-Coded Aﬃnity Tag (ICAT),
Stable Isotope Labeling by Amino Acids in Cell Culture
(SILAC), 15N/ 14N metabolic labeling, 18O/ 16O enzymatic
labeling, Isotope Coded Protein Labeling (ICPL), Tandem
Mass Tags (TMT), Isobaric Tags for Relative and Absolute
Quantiﬁcation (iTRAQ), and other chemical labeling [7, 8].
Thesestableisotopelabelingmethodshaveprovidedvaluable
ﬂexibility while using quantitative proteomic techniques to
study protein changes in complex samples. However, most
labeling-based quantiﬁcation approaches have potential lim-
itations. These include increased time and complexity of
sample preparation, requirement for higher sample con-
centration, high cost of the reagents, incomplete labeling,2 Journal of Biomedicine and Biotechnology
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Figure 1: General approaches of quantitative proteomics. (a) Shotgun isotope labeling method. After labeling by light and heavy stable
isotope, the control and sample are combined and analyzed by LC-MS/MS. The quantiﬁcation is calculated based on the intensity ratio
of isotope-labeled peptide pairs. (b) Label-free quantitative proteomics. Control and sample are subject to individual LC-MS/MS analysis.
Quantiﬁcation is based on the comparison of peak intensity of the same peptide or the spectral count of the same protein.
and the requirement for speciﬁc quantiﬁcation software.
Moreover,sofaronlyTMTandiTRAQallowthecomparison
of multiple (up to 8) samples at the same time. The other
labeling methods can only compare the relative quantity
o fap r o t e i nb e t w e e n2a n d3d i ﬀerent samples. There
has, therefore, been increased interest in label-free shotgun
proteomics techniques in order to address some of the issues
of labeling methods and achieve faster, cleaner, and simpler
quantiﬁcation results [7, 9–11].
2.Label-FreeQuantitativeProteomics
Regardless of which label-free quantitative proteomics
method is used, they all include the following fundamental
steps: (i) sample preparation including protein extraction,
reduction, alkylation, and digestion; (ii) sample separation
by liquid chromatography (LC or LC/LC) and analysis
by MS/MS; (iii) data analysis including peptide/protein
identiﬁcation, quantiﬁcation, and statistical analysis. In
protein-labeling approaches, diﬀerent protein samples are
combined together once labeling is ﬁnished and the pooled
mixtures are then taken through the sample preparation step
before being analyzed by a single LC-MS/MS or LC/LC-
MS/MSexperiment(Figure 1(a)).Incontrast,withlabel-free
quantitative methods, each sample is separately prepared,
then subjected to individual LC-MS/MS or LC/LC-MS/MS
runs (Figure 1(b)). Protein quantiﬁcation is generally based
on two categories of measurements. In the ﬁrst are the
measurements of ion intensity changes such as peptide peak
areas or peak heights in chromatography. The second is
based on the spectral counting of identiﬁed proteins after
MS/MS analysis. Peptide peak intensity or spectral count is
measured for individual LC-MS/MS or LC/LC-MS/MS runs
and changes in protein abundance are calculated via a direct
comparison between diﬀerent analyses.
2.1. Relative Quantiﬁcation by Peak Intensity of LC-MS. In
LC-MS,anionwithaparticularm/zisdetectedandrecorded
with a particular intensity, at a particular time. It has been
observed that signal intensity from electrospray ionization
(ESI) correlates with ion concentration [12]. The label-
free quantiﬁcation of peptide/protein via peak intensity in
LC-MS was ﬁrst studied by loading 10fmol–100pmol of
myoglobin digests to nano-LC and analyzing by LC/MS/MS
[13]. When the chromatographic peak areas of the identiﬁed
peptides were extracted and calculated, the peak areas were
found to increase with increased concentration of injected
peptides. After the peak areas of all identiﬁed myoglobin
peptides were combined and plotted against the protein
amount, the peak area was found to correlate linearly to
the concentration of protein (r2 = 0.991). The strong
correlation between chromatographic peak areas and theJournal of Biomedicine and Biotechnology 3
peptide/protein concentration remained when myoglobin
was spiked into a complex mixture (human serum) and
its digests were detected by LC-MS/MS. The results of
quantitative proﬁling were further improved by normalizing
the calculated peak areas [13, 14].
Although these early studies showed that the relative
quantiﬁcation of the peptides could be achieved via direct
comparison of peak intensity of each peptide ion in
multiple LC-MS datasets, applying this method for the
analysis of changes in protein abundances in complex
biological samples had some practical constraints. First,
even the same sample can result in diﬀerences in the
peak intensities of the peptides from run to run. These
diﬀerences are caused by experimental variations such as
diﬀerences in sample preparation and sample injection.
Normalization is required to account for this kind of
variation. Second, any experimental drifts in retention time
and m/z will signiﬁcantly complicate the direct, accurate
comparison of multiple LC-MS datasets. Chromatographic
shifts may occur as a result of multiple sample injections
onto the same reverse-phase LC column. Unaligned peak
comparison will result in large variability and inaccuracy
in quantiﬁcation. Thus, highly reproducible LC-MS and
careful chromatographic peak alignment are required and
critical in this comparative approach. Last, the large volume
of data collected during LC-MS/MS analysis of complex
protein mixtures requires the data analysis of these spectra
to be automated. Therefore, capable computer algorithms
were developed in the later studies in order to solve
these issues and automatically compare the peak intensity
data between LC-MS samples at a comprehensive scale.
Several similar steps in data processing were performed
in these label-free quantiﬁcations. Peptide peaks were ﬁrst
distinguished from background noise and from neighboring
peaks (peak detection). Isotope patterns were assigned
by deconvolution. LC-MS retention times were carefully
adjusted in order to correctly match the corresponding
mass peaks between multiple LC-MS runs (peak matching).
Chromatographic peak intensity (either peak area or peak
height) was calculated and normalized to enable a more
accurate matching and quantitation. Finally, statistical anal-
ysis such as Students t-test was performed to determine
the signiﬁcance of changes between multiple samples [15–
17].
Automatic comparison of peak intensity from multiple
LC-MS datasets is well suited for clinical biomarker dis-
covery, which normally requires high sample throughput.
The following studies were all performed using this label-
free quantitative approach. The comparison of control and
radiated human colon cancer cells proved the reproducibility
of this label-free approach [18]; the serum proteomic
proﬁlingoffamilialadenomatouspolyposispatientsrevealed
multiple novel celecoxib-modulated proteins [19]; proteins
signiﬁcantly associated with metastasis were identiﬁed by
analyzing paraﬃn-embedded archival melanomas [20]; the
analysis of 55 clinical serum samples from schizophrenia
patients and healthy volunteers identiﬁed hundreds of dif-
ferentiallyexpressedserumproteins [21];diagnostic markers
and protein signatures were recognized from the serum
of Gaucher patients [22] and the cerebrospinal ﬂuid of
schizophrenia patients [23].
2.2. Relative Quantiﬁcation by Spectral Count. In the spec-
tral counting approach, relative protein quantiﬁcation is
achieved by comparing the number of identiﬁed MS/MS
spectra from the same protein in each of the multiple LC-
MS/MS or LC/LC-MS/MS datasets. This is possible because
an increase in protein abundance typically results in an
increase in the number of its proteolytic peptides, and vice
versa.Thisincreasednumberof(tryptic)digeststhenusually
results in an increase in protein sequence coverage, the
number of identiﬁed unique peptides, and the number of
identiﬁed total MS/MS spectra (spectral count) for each
protein [24]. Liu et al. studied the correlation between
relative protein abundance and sequence coverage, peptide
number,andspectralcount.Itwasdemonstratedthatamong
all the factors of identiﬁcation, only spectral count showed
strong linear correlation with relative protein abundance
(r2 = 0.9997) with a dynamic range over 2 orders of
magnitude [25]. Therefore, spectral count can be used as a
simple but reliable index for relative protein quantiﬁcation.
An intriguing study evaluated relative quantiﬁcation of
protein complex by spectral counting-based method and
15N/ 14Nisotopelabeled,ionchromatographicmethod[26].
The crude membrane proteins extracted from S. cerevisiae
grown in rich and minimal media were analyzed by MudPIT
and quantiﬁed using both approaches. It was found that
the two quantitative methods showed a strong correlation
when the peptides with high signal-to-noise ratio in the
extracted ion chromatogram were used in the comparison.
Moreover, spectral counting-based quantiﬁcation is proved
more reproducible and has a larger dynamic range than the
peptide ion chromatogram-based quantiﬁcation [26].
In contrast to the chromatographic peak intensity
approach, which requires delicate computer algorithms for
automatic LC-MS peak alignment and comparison, no
speciﬁc tools or algorithms have been developed specially
for spectral counting due to its ease of implementation.
However, normalization and statistical analysis of spectral
counting datasets are necessary for accurate and reliable
detection of protein changes in complex mixtures. A simple
normalization method based on total spectral counts has
been reported to account for the variation from run to
run [27]. Since large proteins tend to contribute more
peptide/spectra than small ones, a normalized spectral
abundance factor (NSAF) was deﬁned to account for the
eﬀect of protein length on spectral count [28, 29]. NSAF is
calculatedasthenumberofspectralcounts(SpC)identifying
a protein, divided by the protein’s length (L), divided by
the sum of SpC/L for all proteins in the experiment. NSAF
allows the comparison of abundance of individual proteins
in multiple independent samples and has been applied to
quantify the expression changes in various complexes [29,
30].
Five diﬀerent statistical tests have been compared by
Zhang et al. to evaluate the signiﬁcance of comparative
quantiﬁcationbyspectralcounts[31].TheFisher’sexacttest,4 Journal of Biomedicine and Biotechnology
Table 1: Commercially available software for label-free analysis.
Software Producer Quantiﬁcation Website
Decyder MS GE Healthcare Peak intensity http://www5.gelifesciences.com/
SIEVE Thermo Electron Peak intensity http://www.thermo.com/
Elucidator Rosetta Peak intensity, spectral count http://www.rosettabio.com/
ProteinLynx Waters Peak intensity http://www.waters.com/
goodness-of-ﬁt test (G-test), AC test, Student’s t-test, and
Local-Pooled-Error (LPE) test were performed on spectral
count data collected by MudPIT analysis of yeast digests.
The Student’s t-test was found to be the best when three or
more replicates are available. The Fisher’s exact test, G-test,
and AC test can be used when the number of replications is
limited (one or two), while G-test has the advantage due to
its computational simplicity.
Relative quantiﬁcation by spectral count has been widely
applied in diﬀerent biological complex, including analysis
of urine sample from healthy donors and patients with
acuteinﬂammation[32],ﬁndingbiomarkersinhumansaliva
proteome in type-2 diabetes [33], comparison of protein
expression in yeast and mammalian cells under diﬀerent
culture conditions [11, 26, 29], distinguishing lung cancer
from normal [34], screening of phosphotyrosine-binding
proteinsinmammaliancells[35],andidentifyingdiﬀerential
plasma membrane proteins from terminally diﬀerentiated
m o u s ec e l ll i n e s[ 36].
2.3. Absolute Label-Free Quantiﬁcation. In addition to rela-
tive quantiﬁcation, label-free proteomics methods can also
be used in the determination of absolute abundance of
proteins. Protein abundance index (PAI), deﬁned as the
number of identiﬁed peptides divided by the number of
theoreticallyobservabletrypticpeptidesforeachprotein,was
used to estimate protein abundance in human spliceosome
complex [37]. This index was later converted to exponen-
tially modiﬁed PAI (emPAI, the exponential form of PAI
minus one) [38]. The emPAI demonstrated its success by
determining absolute abundance of 46 proteins in a mouse
whole-cell lysate, which had been measured using synthetic
peptides. The values of emPAI can be calculated easily with a
simple script and do not require additional experimentation
in protein identiﬁcation experiments. It can be routinely
used for reporting approximate absolute protein abundance
in a large-scale analysis.
Recently, a modiﬁed spectral counting strategy termed
absolute protein expression (APEX) proﬁling was developed
to measure the absolute protein concentration per cell from
the proportionality between the protein abundance and the
number of peptides observed [39]. The key to APEX is the
introduction of appropriate correction factors that make the
fraction of expected number of peptides and the fraction of
observed number of peptides proportional to one another.
The protein’s absolute abundance is indicated by an APEX
score, which is calculated from the fraction of observed
peptide mass spectra associated with one protein, corrected
by the prior estimate of the number of unique peptides
expected from a given protein during a MudPIT experiment.
The critical correction factor for each protein (called Oi
value) is calculated by using a machine learning classiﬁcation
algorithm to predict the observed tryptic peptides from a
given protein based upon peptide length and amino acid
composition. APEX successfully determined the abundance
of 10 proteins that were spiked in a yeast cell extract with
known amounts. The absolute protein abundance of yeast
and E. coli p r o t e o m e sa n a l y z e db yA P E Xc o r r e l a t e dw e l lw i t h
the measurements from other absolute expression measure-
ments suchas high-throughput analysisof fusionproteins by
western blotting or ﬂow cytometry. The APEX technique has
recently been developed as APEX Quantitative Proteomics
Tool [40], a free open source Java implementation for the
absolute quantiﬁcation of proteins (http://pfgrc.jcvi.org/).
3. Commercially Available Softwarefor
Label-FreeQuantitativeProteomics
There has recently been a rapid increase in the development
of new bioinformatics tools that aid in automated label-
free analysis for comparative LC-MS. The data processing
pipelines generally include data normalization, time align-
ment, peak detection, peak quantiﬁcation, peak matching,
identiﬁcation,andstatisticalanalysis.Numerousopensource
and commercial software are available currently. The open
source programs include MapQuant, MZmine, MsInspect,
OpenMs, MSight, SuperHirn, and PEPPeR [41, 42]. The
commercially available software is listed in Table 1.D e c y d e r
MS is based on DeCyder 2D Diﬀerential Analysis Software. It
consists of two main analysis features: peptide detection with
the PepDetect module and run-to-run matching with the
PepMatch module. PepDetect module provides background
subtraction, isotope and charge-state deconvolution, and
peak volume calculations using imaging algorithms. This
module also provides the option of submitting all or a
selected subset of peptides for protein identiﬁcation by
database searching. PepMatch module aligns peptides from
diﬀerent LC-MS runs and detects small quantitative diﬀer-
ences between peptides across multiple runs with statistical
conﬁdence.Various normalization techniquescanbeapplied
to further improve results [18].
SIEVE software employs an algorithm called ChromA-
lign for chromatographic alignment prior to ﬁnd diﬀerences
that are statistically meaningful. The software can determine
a P-value for the expression ratio of each diﬀerential peak,
providing an extra measure of conﬁdence. Peptides that
show statistically signiﬁcant diﬀerences can be searched
against protein databases to determine peptide and proteinJournal of Biomedicine and Biotechnology 5
identities. Its preﬁltering function reduces the number of
spectra that need to be searched, decreases the time spent
on identiﬁcation, and increases the throughput of complex
biomarker discovery experiments.
The Rosetta Elucidator system is not only a label-
free quantitative software, but also a data management
platform to store and manage large volumes of MS data.
It also supports labeling analysis such as SILAC and ICAT.
ElucidatorusesanalgorithmcalledPeakTellerforpeakdetec-
tion, extraction, and quantitation from mass spectrometry
data. It uses PeptideTeller and ProteinTeller for verifying
correct peptide/protein assignments for all features. The
system supports a wide range of MS instruments, database
search algorithms, comprehensive visualization and analysis
tools [43]. It supports label-free quantiﬁcation by spectral
counting as well.
ProteinLynxGlobalServersupportslabel-freequantiﬁca-
tion by peak intensity. It is also a database searching engine
for peptide/protein identiﬁcation [21, 23].
4. Conclusions
The rapid development of label-free quantitative proteomic
techniques has provided fast and low-cost measurement
of protein expression levels in complex biological sam-
ples. Peak intensity-based comparative LC-MS and spectral
count-based LC-MS/MS are the two most commonly used
label-free quantiﬁcation methods. Compared with isotope-
labeling methods, label-free experiments need to be more
carefully controlled, due to possible error caused by run-
to-run variations in performance of LC and MS. How-
ever, the development of highly reproducible nano-HPLC
separation, high resolution mass spectrometer, and delicate
computational tools has greatly improved the reliability and
accuracy of label-free, comparative LC-MS. Commercially
available data processing software is able to automatically
detect, match, and analyze peptides from hundreds of dif-
ferent LC-MS experiments simultaneously, which provides
a high-throughput technique for disease-related biomarker
discovery. The spectral count-based label-free method pos-
itively correlates with isotope-labeling quantiﬁcation and
allows both relative and absolute quantiﬁcation of protein
abundance. These label-free quantitative approaches have
provided rigorous, powerful tools for analyzing protein
changes in large-scale proteomics studies.
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